[Fire Fighting] Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. To extinguish fire, use water fog, dry chemical, carbon dioxide, or regular foam. | |
[Ingestion] If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately. | |
[Inhalation] Get medical aid immediately. Remove from exposure to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. | |
[Skin] Get medical aid immediately. Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. | |
[Eyes] Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately. | |
[Storage] Store in a cool, dry place. Keep container closed when not in use. | |
[Handling] Wash thoroughly after handling. Use only in a well ventilated area. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. | |
[Ingestion] Harmful if swallowed. Causes gastrointestinal tract irritation. | |
[Inhalation] The toxicological properties of this substance have not been fully investigated. | |
[Skin] No information regarding skin irritation and other potential effects was found. | |
[Eyes] No information regarding eye irritation and other potential effects was found. | |
[Personal Protection] Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. | |
[Respirators] Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary. | |
[Appearance] White solid. | |
[Melting Point] 115-116 | |
[Usage] Dilatation of ductus arteriosus in infants with ductal dependent congenital heart defects. | |
[Product Name] 11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid | |
[Synonyms] Alprostadil Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l Prost-13-en-1-oic acid Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15S)- Prostin VR Pediatric SEPA-prostaglandin E1 | |
[CAS] "CASEN_745-65-3.htm">745-65-3 | |
[Formula] C20H34O5 | |
[Molecular Weight] 354.48 | |
[EINECS] 212-017-2 | |
[RTECS] GY4569800 | |
[RTECS Class] Mutagen; Reproductive Effector; Human Data; Hormone | |
[Merck] 12,8063 | |
[Beilstein/Gmelin] 1890728 | |
[Small spills/leaks] Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions. | |
[Stability] Stable under normal temperatures and pressures. | |
[Incompatibilities] Strong oxidizing agents. | |
[Decomposition] Carbon monoxide, carbon dioxide. |